Society for Research on Nicotine and Tobacco
Society for Research on Nicotine and Tobacco (SRNT) is a leading global organization dedicated to the scientific study of nicotine and tobacco. It was established with the goal of fostering research across a wide range of disciplines to understand the complex effects of nicotine and tobacco on health, as well as to inform policies and practices related to tobacco control and cessation. The SRNT plays a crucial role in bringing together researchers, clinicians, public health professionals, and policymakers to share findings, discuss challenges, and collaborate on solutions to reduce the harm caused by tobacco use.
History[edit]
The Society for Research on Nicotine and Tobacco was founded in the early 1990s by a group of scientists and researchers committed to understanding the effects of nicotine and tobacco on health, addiction, and society. Since its inception, the SRNT has grown significantly, both in terms of membership and its influence on tobacco research and policy.
Mission and Goals[edit]
The primary mission of the SRNT is to advance research on nicotine and tobacco, with a focus on improving public health worldwide. Its goals include promoting the generation and dissemination of evidence-based information on nicotine and tobacco, supporting the development of effective tobacco control and cessation interventions, and influencing public policy and regulations related to tobacco use.
Activities and Programs[edit]
The SRNT organizes an annual scientific conference that serves as a platform for members to present their research, engage in discussions, and network with peers. These conferences cover a broad range of topics, including the pharmacology of nicotine, the epidemiology of tobacco use, tobacco addiction, cessation strategies, regulatory science, and the social, economic, and environmental impacts of tobacco.
In addition to its annual conference, the SRNT publishes a peer-reviewed journal, Nicotine & Tobacco Research, which is a leading source of scientific information on nicotine and tobacco. The journal features original research articles, reviews, and commentaries on all aspects of nicotine and tobacco research.
The society also offers various resources and support for researchers, including funding opportunities, awards to recognize outstanding contributions to the field, and educational materials to help disseminate research findings to a broader audience.
Membership[edit]
Membership in the SRNT is open to anyone interested in nicotine and tobacco research, including scientists, clinicians, public health professionals, and policymakers. Members benefit from access to the society's journal, opportunities to participate in the annual conference, and a network of professionals committed to reducing the harm caused by tobacco use.
Impact[edit]
The SRNT has made significant contributions to the field of nicotine and tobacco research. Its members have been at the forefront of major scientific discoveries and have played a key role in shaping public health policies and tobacco control measures around the world. The society's efforts have contributed to a deeper understanding of the health effects of tobacco use, the development of effective cessation interventions, and the implementation of policies to reduce tobacco-related harm.
Challenges and Future Directions[edit]
Despite the progress made in tobacco control, tobacco use remains a leading cause of preventable death and disease worldwide. The SRNT continues to face challenges, including the emergence of new tobacco products, such as electronic cigarettes, and the ongoing need to adapt tobacco control strategies to changing patterns of use. The society is committed to addressing these challenges through research, collaboration, and advocacy to achieve its mission of improving public health.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
